These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3521473

  • 1. In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Fernandes PB, Chu DT, Bower RR, Jarvis KP, Ramer NR, Shipkowitz N.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):201-8. PubMed ID: 3521473
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritis.
    Meulbroek JA, Oleksijew A, Tanaka SK, Alder JD.
    J Antimicrob Chemother; 1996 Oct; 38(4):641-53. PubMed ID: 8937959
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents.
    Smith BR, LeFrock JL, Donato JB, Joseph WS, Weber SJ.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):355-8. PubMed ID: 3717937
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy: a way to limit emergence of resistance?
    Michéa-Hamzehpour M, Pechère JC, Marchou B, Auckenthaler R.
    Am J Med; 1986 Jun 30; 80(6B):138-42. PubMed ID: 3088999
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1987 Jul 30; 31(7):1085-92. PubMed ID: 3310868
    [Abstract] [Full Text] [Related]

  • 14. A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.
    Fernandes PB, Chu DT, Swanson RN, Ramer NR, Hanson CW, Bower RR, Stamm JM, Hardy DJ.
    Antimicrob Agents Chemother; 1988 Jan 30; 32(1):27-32. PubMed ID: 3348609
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
    Nakamura S, Minami A, Nakata K, Kurobe N, Kouno K, Sakaguchi Y, Kashimoto S, Yoshida H, Kojima T, Ohue T.
    Antimicrob Agents Chemother; 1989 Aug 30; 33(8):1167-73. PubMed ID: 2802544
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
    Chu DT, Fernandes PB, Claiborne AK, Pihuleac E, Nordeen CW, Maleczka RE, Pernet AG.
    J Med Chem; 1985 Nov 30; 28(11):1558-64. PubMed ID: 3934382
    [Abstract] [Full Text] [Related]

  • 20. Comparative activities of norfloxacin and fleroxacin in experimental infections due to Salmonella typhimurium and Escherichia coli.
    Hof H, Fabrig J.
    J Antimicrob Chemother; 1988 Oct 30; 22 Suppl D():123-7. PubMed ID: 3144530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.